{"id":882,"date":"2017-12-18T09:00:23","date_gmt":"2017-12-18T09:00:23","guid":{"rendered":"http:\/\/impulse-dynamics-multisite.flywheelsites.com\/ous\/?p=882"},"modified":"2024-01-17T04:29:15","modified_gmt":"2024-01-17T09:29:15","slug":"the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china","status":"publish","type":"post","link":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/","title":{"rendered":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.0.6&#8243; custom_padding=&#8221;||2px|||&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; _builder_version=&#8221;4.0.4&#8243; background_color=&#8221;#00a1e4&#8243; width=&#8221;100%&#8221; max_width=&#8221;1920px&#8221; min_height=&#8221;462px&#8221; custom_margin=&#8221;-56px|auto||auto|false|false&#8221; custom_padding=&#8221;||0px|||&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.4&#8243;][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.6&#8243;][et_pb_text _builder_version=&#8221;4.0.6&#8243; header_2_font=&#8221;|300|||||||&#8221; header_2_text_color=&#8221;#ffffff&#8221; header_2_font_size=&#8221;80px&#8221; header_2_letter_spacing=&#8221;5px&#8221; custom_margin=&#8221;78px||||false|false&#8221;]<\/p>\n<h2 style=\"text-align: center;\">NEWS<\/h2>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#005496&#8243; _builder_version=&#8221;4.0.4&#8243; width=&#8221;53%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;36px||||false|false&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.0.6&#8243; header_font=&#8221;|||on|||||&#8221; header_4_font=&#8221;|||on|||||&#8221; header_4_text_color=&#8221;#FFFFFF&#8221; header_4_font_size=&#8221;30px&#8221;]<\/p>\n<h4 style=\"text-align: center;\">The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China<\/h4>\n<p>[\/et_pb_text][et_pb_divider color=&#8221;#005496&#8243; _builder_version=&#8221;4.0.4&#8243; width=&#8221;53%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;16px||||false|false&#8221;][\/et_pb_divider][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.4&#8243;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.0.6&#8243; custom_padding=&#8221;0px|||||&#8221;][et_pb_row _builder_version=&#8221;4.0.6&#8243; custom_padding=&#8221;||0px|||&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.0.6&#8243;][et_pb_text _builder_version=&#8221;4.0.6&#8243; header_2_text_color=&#8221;#005496&#8243; custom_margin=&#8221;||7px|||&#8221; custom_padding=&#8221;||0px|||&#8221;]<\/p>\n<p><strong>Orangeburg, New York &amp; Stuttgart, Germany. December 18, 2017 \u2013\u00a0<\/strong>The China Food and Drug Administration (CFDA) has approved Impulse Dynamics\u2019 Optimizer\u00ae system for treatment of chronic heart failure.\u00a0 The announcement was made on December 12, 2017 by Impulse Dynamics\u2019 CEO, Dr. Simos Kedikoglou.\u00a0 \u201cThis is a major milestone for Impulse Dynamics, as it will help us offer Cardiac Contractility Modulation therapy to many patients in China who are in need of heart failure symptom relief.\u00a0 It is also indicative of the efforts and investments the company has made in China, as we are one of the very few private companies that have reached such an achievement in-house, reflecting the dedication and commitment of the company\u2019s employees globally,\u201d said Dr. Kedikoglou.<\/p>\n<p>The implantable Optimizer device delivers non-excitatory Cardiac Contractility Modulation signals to the heart muscle, and initiates multiple biochemical and neurohormonal changes to the myocardium. \u00a0As a result, the contractility of the myocardium increases with no concomitant increase in oxygen consumption, enabling the heart to operate more efficiently. \u00a0The Optimizer\u00ae has been successfully implanted in over 3,500 patients worldwide to date, and Cardiac Contractility Modulation technology is approved for sale in Europe, Australia, Brazil, India, New Zealand and Hong Kong. \u00a0The device is also referenced in the 2016 European Heart Failure Association guidelines as a potential treatment for heart failure patients.<\/p>\n<p>Dr. Kedikoglou said that Impulse Dynamics is committed to developing its operations in China and making Cardiac Contractility Modulation and the Optimizer\u00ae available to Chinese heart failure patients with the approved indication. \u00a0The company plans to start commercial sales in China in due course.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.0.6&#8243; background_color=&#8221;#005496&#8243; custom_padding=&#8221;37px|36px|37px|36px|true|true&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.6&#8243;][et_pb_text _builder_version=&#8221;4.0.6&#8243; background_layout=&#8221;dark&#8221;]<\/p>\n<p><strong>About the Optimizer and CCM Therapy<br \/> <\/strong>CCM is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device during the absolute refractory period of the heart\u2019s cardiac cycle to improve systolic contraction of the heart. The Optimizer System has been implanted in over 4,000 patients and is currently available in the US, Europe, China, Brazil, India, and more than 40 other countries around the world. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.6&#8243;][et_pb_text _builder_version=&#8221;4.0.6&#8243; background_layout=&#8221;dark&#8221;]<\/p>\n<p><strong>About Impulse Dynamics<br \/> <\/strong>Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in; Stuttgart, Germany, Orangeburg, N.Y. and Curacao For more information please visit<span>\u00a0<\/span><a href=\"https:\/\/impulse-dynamics.com\/ous\/\">www.impulse-dynamics.com<\/a>.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.6&#8243;][et_pb_text _builder_version=&#8221;4.0.6&#8243; background_layout=&#8221;dark&#8221;]<\/p>\n<p><strong>Impulse Dynamics (USA), Inc.<\/strong><br \/> 523 Fellowship Road, Suite 203<br \/> Mt. Laurel, NJ 08054<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.0.4&#8243; background_color=&#8221;#005496&#8243; custom_margin=&#8221;-8px|||||&#8221; custom_padding=&#8221;0px||0px||true&#8221; global_module=&#8221;79&#8243; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.0.6&#8243; max_width=&#8221;1400px&#8221; custom_padding=&#8221;15px||5px||false&#8221; custom_padding_tablet=&#8221;0px||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_signup mailchimp_list=&#8221;Impulse Dynamics|b1aca3c5b7&#8243; ip_address=&#8221;off&#8221; first_name_field=&#8221;off&#8221; last_name_field=&#8221;off&#8221; title=&#8221;IMPULSE DYNAMICS NEWSLETTER&#8221; button_text=&#8221;SIGN UP&#8221; description=&#8221;<\/p>\n<p>Sign up to receive our monthly newsletter <\/p>\n<p>&#8221; footer_content=&#8221;<\/p>\n<p>We take your privacy seriously. No spam. See our <a href=%22\/terms-of-use\/%22>terms &#038; privacy here<\/a>.<\/p>\n<p>&#8221; admin_label=&#8221;Slim Email Optin #1&#8243; module_class=&#8221;dl-slim-optin1&#8243; _builder_version=&#8221;4.0.6&#8243; header_font=&#8221;|700|||||||&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.3em&#8221; background_enable_color=&#8221;off&#8221; custom_button=&#8221;on&#8221; button_bg_color=&#8221;#00a1e4&#8243; button_border_width=&#8221;0px&#8221; button_border_radius=&#8221;0px&#8221; custom_margin=&#8221;|||&#8221; custom_padding=&#8221;|||&#8221; header_font_size_tablet=&#8221;22px&#8221; header_font_size_phone=&#8221;20px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_radii_fields=&#8221;on|0px|0px|0px|0px&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_signup][et_pb_code admin_label=&#8221;CSS Code &#8211; Optin #3&#8243;]<\/p>\n<style><!-- [et_pb_line_break_holder] -->\/* Divi Lover Slim Optin Form *\/<!-- [et_pb_line_break_holder] -->\/* Optional - copy the CSS to page options, theme options or child theme stylesheet *\/<!-- [et_pb_line_break_holder] -->.dl-slim-optin1 .et_pb_newsletter_footer {<!-- [et_pb_line_break_holder] --> flex-basis: 100%;<!-- [et_pb_line_break_holder] --> margin-top: 0;<!-- [et_pb_line_break_holder] --> font-size: 80%;<!-- [et_pb_line_break_holder] -->} <!-- [et_pb_line_break_holder] -->.dl-slim-optin1 .et_pb_newsletter_field,<!-- [et_pb_line_break_holder] -->.dl-slim-optin1 .et_pb_newsletter_button_wrap {<!-- [et_pb_line_break_holder] --> flex-basis:49%;<!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] -->@media (max-width:980px) {<!-- [et_pb_line_break_holder] --> .et_pb_column_4_4 .dl-slim-optin1 {<!-- [et_pb_line_break_holder] --> display:block;<!-- [et_pb_line_break_holder] --> }<!-- [et_pb_line_break_holder] --> .dl-slim-optin1 .et_pb_newsletter_description,<!-- [et_pb_line_break_holder] --> .dl-slim-optin1 .et_pb_newsletter_form {<!-- [et_pb_line_break_holder] --> width: 100%;<!-- [et_pb_line_break_holder] --> padding: 0;<!-- [et_pb_line_break_holder] --> }<!-- [et_pb_line_break_holder] --> .et_pb_column_4_4 .dl-slim-optin1 .et_pb_newsletter_description {<!-- [et_pb_line_break_holder] --> margin-bottom: 10px;<!-- [et_pb_line_break_holder] --> text-align:center;<!-- [et_pb_line_break_holder] --> }<!-- [et_pb_line_break_holder] --> .dl-slim-optin1 .et_pb_newsletter_footer {<!-- [et_pb_line_break_holder] --> text-align:center;<!-- [et_pb_line_break_holder] --> }<!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] -->@media (max-width:479px) {<!-- [et_pb_line_break_holder] --> .dl-slim-optin1 .et_pb_newsletter_field,<!-- [et_pb_line_break_holder] --> .dl-slim-optin1 .et_pb_newsletter_button_wrap {<!-- [et_pb_line_break_holder] --> flex-basis:100%;<!-- [et_pb_line_break_holder] --> }<!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] -->\/* END *\/ <!-- [et_pb_line_break_holder] --><\/style>\n<p>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.0.4&#8243; custom_padding=&#8221;||0px|||&#8221; global_module=&#8221;81&#8243; saved_tabs=&#8221;all&#8221;][et_pb_row column_structure=&#8221;1_3,2_3&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; _builder_version=&#8221;4.0.4&#8243; width=&#8221;100%&#8221; max_width=&#8221;1400px&#8221; custom_margin=&#8221;-37px|auto||auto||&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.0.4&#8243;][et_pb_image src=&#8221;http:\/\/impulsedynamics.aktionstaging.com\/wp-content\/uploads\/sites\/2\/2019\/11\/19-09-25-ID-Coporate-Logo.png&#8221; _builder_version=&#8221;4.0.6&#8243; width=&#8221;87%&#8221; width_tablet=&#8221;66%&#8221; width_phone=&#8221;73%&#8221; width_last_edited=&#8221;on|tablet&#8221; module_alignment_tablet=&#8221;center&#8221; module_alignment_phone=&#8221;center&#8221; module_alignment_last_edited=&#8221;on|tablet&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.0.6&#8243; custom_margin=&#8221;45px||||false|false&#8221; custom_margin_tablet=&#8221;|118px||118px|false|true&#8221; custom_margin_phone=&#8221;|123px||123px|false|true&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221;]<\/p>\n<p>\u00a9 2019 Impulse Dynamics\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<a href=\"\/terms-of-use\/\">Terms of Use<\/a> | <a href=\"\/data-protection-statement\/\">Data Protection<\/a>\u00a0<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.0.4&#8243;][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEWSThe CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in ChinaOrangeburg, New York &amp; Stuttgart, Germany. December 18, 2017 \u2013\u00a0The China Food and Drug Administration (CFDA) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-882","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics\" \/>\n<meta property=\"og:description\" content=\"NEWSThe CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in ChinaOrangeburg, New York &amp; Stuttgart, Germany. December 18, 2017 \u2013\u00a0The China Food and Drug Administration (CFDA) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/\" \/>\n<meta property=\"og:site_name\" content=\"Global - Impulse Dynamics\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-18T09:00:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-17T09:29:15+00:00\" \/>\n<meta name=\"author\" content=\"Impulse Dynamics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Impulse Dynamics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/\"},\"author\":{\"name\":\"Impulse Dynamics\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/#\\\/schema\\\/person\\\/d391c20c2d51870c9b2930c084bcdb2c\"},\"headline\":\"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China\",\"datePublished\":\"2017-12-18T09:00:23+00:00\",\"dateModified\":\"2024-01-17T09:29:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/\"},\"wordCount\":1255,\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/\",\"url\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/\",\"name\":\"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/#website\"},\"datePublished\":\"2017-12-18T09:00:23+00:00\",\"dateModified\":\"2024-01-17T09:29:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/#\\\/schema\\\/person\\\/d391c20c2d51870c9b2930c084bcdb2c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/#website\",\"url\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/\",\"name\":\"Global - Impulse Dynamics\",\"description\":\"heart failure treatment | Impulse Dynamics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/#\\\/schema\\\/person\\\/d391c20c2d51870c9b2930c084bcdb2c\",\"name\":\"Impulse Dynamics\",\"description\":\"Here is my biographical information\",\"url\":\"https:\\\/\\\/impulse-dynamics.com\\\/global\\\/author\\\/mattwadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/","og_locale":"en_US","og_type":"article","og_title":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics","og_description":"NEWSThe CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in ChinaOrangeburg, New York &amp; Stuttgart, Germany. December 18, 2017 \u2013\u00a0The China Food and Drug Administration (CFDA) [&hellip;]","og_url":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/","og_site_name":"Global - Impulse Dynamics","article_published_time":"2017-12-18T09:00:23+00:00","article_modified_time":"2024-01-17T09:29:15+00:00","author":"Impulse Dynamics","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Impulse Dynamics","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/#article","isPartOf":{"@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/"},"author":{"name":"Impulse Dynamics","@id":"https:\/\/impulse-dynamics.com\/global\/#\/schema\/person\/d391c20c2d51870c9b2930c084bcdb2c"},"headline":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China","datePublished":"2017-12-18T09:00:23+00:00","dateModified":"2024-01-17T09:29:15+00:00","mainEntityOfPage":{"@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/"},"wordCount":1255,"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/","url":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/","name":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China - Global - Impulse Dynamics","isPartOf":{"@id":"https:\/\/impulse-dynamics.com\/global\/#website"},"datePublished":"2017-12-18T09:00:23+00:00","dateModified":"2024-01-17T09:29:15+00:00","author":{"@id":"https:\/\/impulse-dynamics.com\/global\/#\/schema\/person\/d391c20c2d51870c9b2930c084bcdb2c"},"breadcrumb":{"@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/impulse-dynamics.com\/global\/the-cfda-approves-impulse-dynamics-optimizer-system-for-treatment-of-chronic-heart-failure-in-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/impulse-dynamics.com\/global\/"},{"@type":"ListItem","position":2,"name":"The CFDA Approves Impulse Dynamics\u2019 Optimizer System for Treatment of Chronic Heart Failure in China"}]},{"@type":"WebSite","@id":"https:\/\/impulse-dynamics.com\/global\/#website","url":"https:\/\/impulse-dynamics.com\/global\/","name":"Global - Impulse Dynamics","description":"heart failure treatment | Impulse Dynamics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/impulse-dynamics.com\/global\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/impulse-dynamics.com\/global\/#\/schema\/person\/d391c20c2d51870c9b2930c084bcdb2c","name":"Impulse Dynamics","description":"Here is my biographical information","url":"https:\/\/impulse-dynamics.com\/global\/author\/mattwadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/posts\/882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/comments?post=882"}],"version-history":[{"count":3,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/posts\/882\/revisions"}],"predecessor-version":[{"id":886,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/posts\/882\/revisions\/886"}],"wp:attachment":[{"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/media?parent=882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/categories?post=882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/impulse-dynamics.com\/global\/wp-json\/wp\/v2\/tags?post=882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}